MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/curroncol32120705

Медицинская библиотека · Current oncology (Toronto, Ont.) · 2025

The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in BRCA1.

Kotsopoulos Joanne, Apostol Adriana I, Metcalfe Kelly, Jorgji Dimitri, Cybulski Cezary, Gronwald Jacek, Lubinski Jan, Moller Pal, Kim Raymond H, Aeilts Amber, Ramón Y Cajal Teresa, Pal Tuya, Bordeleau Louise, Karlan Beth Y, Singer Christian F, Foulkes William D, Couch Fergus J, Zakalik Dana, Fruscio Robert, Tung Nadine, Sun Ping, Monteiro Alvaro N, Narod Steven A, Akbari Mohammad R, Hereditary Breast Cancer Clinical Study Group

СтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

BACKGROUND

Carriers of a pathogenic variant (PV) in BRCA1 face a high risk of breast cancer. This study estimated the risk of developing breast cancer according to mutation type and location.

METHODS

BRCA1 carriers with no personal history of breast cancer or bilateral mastectomy were included. Detailed information on clinical and family history was collected by questionnaire. Survival analysis was used to estimate 15-year cumulative risk according to PV type and location.

RESULTS

A total of 3677 BRCA1 carriers were followed for a mean of 7.2 years (range 0.1-15.0 years); 481 incident breast cancers were documented. Overall, the 15-year cumulative incidence was 25%. Risk estimates varied by exon, ranging from 9% (exon 21) to 19% (exon 12) to 36% (exon 15); however, strata were small. Carriers of four founder mutations common in Eastern Europe (c.5263_5264insC, c.181T > G, c.66_67delAG and c.4034delA) experienced a lower-than-expected cancer risk (15.9-24.4%) compared to other PVs (28.8%) (p = 0.02).

CONCLUSIONS

Although our data suggests some variability in penetrance based on specific BRCA1 PV, this was based on a large number of founder mutations. Breast cancer management strategies should continue to be based on comprehensive risk assessment.

Для цитирования: Kotsopoulos Joanne, Apostol Adriana I, Metcalfe Kelly, Jorgji Dimitri, Cybulski Cezary, Gronwald Jacek, Lubinski Jan, Moller Pal, Kim Raymond H, Aeilts Amber, Ramón Y Cajal Teresa, Pal Tuya, Bordeleau Louise, Karlan Beth Y, Singer Christian F, Foulkes William D, Couch Fergus J, Zakalik Dana, Fruscio Robert, Tung Nadine, Sun Ping, Monteiro Alvaro N, Narod Steven A, Akbari Mohammad R, Hereditary Breast Cancer Clinical Study Group. The Risk of Breast Cancer According to Mutation Type and Position in Carriers of a Pathogenic Variant in BRCA1.. Current oncology (Toronto, Ont.). 2025. DOI: 10.3390/curroncol32120705.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.